|
|
Volumn 10, Issue 9, 2001, Pages 829-830
|
|
News from the society for women’s health research: FDA doing poor job of monitoring drugs for sex differences
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIODARONE;
ASTEMIZOLE;
BEPRIDIL;
CISAPRIDE;
DISOPYRAMIDE;
ERYTHROMYCIN;
HALOFANTRINE;
IBUTILIDE;
MIBEFRADIL;
PENTAMIDINE;
PIMOZIDE;
PROBUCOL;
QUINIDINE;
SOTALOL;
TERFENADINE;
ARTICLE;
CONTROLLED STUDY;
DATA ANALYSIS;
DATA BASE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG MONITORING;
DRUG RESPONSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MALE;
PRESCRIPTION;
PRIORITY JOURNAL;
SEX DIFFERENCE;
TORSADE DES POINTES;
CLINICAL TRIALS;
DRUG APPROVAL;
FEMALE;
HUMANS;
PATIENT SELECTION;
PHARMACEUTICAL PREPARATIONS;
SEX FACTORS;
SOCIETIES, MEDICAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
WOMEN'S HEALTH;
|
|
EID: 77952578799
PISSN: 15246094
EISSN: None
Source Type: Journal
DOI: 10.1089/152460901753285705 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|